Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02971813 · ClinicalTrials.gov registry record · NA

A Social Media Intervention for Exercise Motivation and Cardiac Rehabilitation Adherence

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT02971813: Completed NA study, sponsored by The Cleveland Clinic.

NCT02971813 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02971813, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

While cardiac rehabilitation (CR) has been shown to be effective at improving cardiovascular disease (CVD), participation is generally poor. The current feasibility study, will evaluate the impact of a social media intervention on motivation for exercise and adherence to CR sessions. Participants will be randomly assigned to a Facebook™ group or an enhanced education comparison group. The intervention will include access to a private Facebook™ group in which participants will receive weekly educational posts, weekly provider support and have the opportunity to communicate with other cardiac rehabilitation patients. Patients in the comparison group will be given the same educational materials, but these will be supplied in email. Participants will be asked to fill out a pre-post motivational questionnaire and the total number of sessions attended at the end of 3 months will be tallied. This study is grounded in Self-Determination Theory (SDT) and utilizes the Behavioral Regulation in Exercise Questionnaire (BREQ-2), which is based on the SDT.

Primary Outcome

Measured using Behavioral Regulation in Exercise Questionnaire-3 (BREQ-3)

Interventions

  • BEHAVIORAL Facebook

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2017-02-27
Est. Completion 2019-03-01
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT02971813 record still lists

NCT02971813 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Facebook is the first listed.

NCT02971813 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02971813 about?

NCT02971813 is a clinical study titled "A Social Media Intervention for Exercise Motivation and Cardiac Rehabilitation Adherence". While cardiac rehabilitation (CR) has been shown to be effective at improving cardiovascular disease (CVD), participation is generally poor. The current feasibility study, will evaluate the impact of a social media intervention on motivation for exercise and adherence to CR sessions. Participants wi...

What is the current status of trial NCT02971813?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-02-27. Estimated completion is 2019-03-01.

What interventions are being tested in trial NCT02971813?

The interventions under investigation include: Facebook (BEHAVIORAL).

Who is sponsoring clinical trial NCT02971813?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02971813's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02971813, the US trial registry maintained by the National Library of Medicine. NCT02971813 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.